Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | SAIL66 |
Synonyms | |
Therapy Description |
SAIL66 is a T-cell engager that targets CLDN6 on cancer cells and also binds to CD3 and TNFRSF9 (CD137), potentially inducing T-cell activation, cytokine release, and antitumor immune activity (J Immunother Cancer 2023;11(Suppl 1):1172). |